Using smartphone technology, researchers can now access Chemical Abstracts Services SciFinder
Chemical Abstracts Service (CAS) has introduced new enhancements to SciFinder, which will provide more synthetic pathways and improve productivity for researchers working in the chemical, pharmaceutical, biotechnology, and energy industries
Chemical Abstracts Service (CAS) has made its SciFinder research tool available over the web.
Chemical Abstracts Service and FIZ Karlsruhe have introduced a more powerful version of the STN AnaVist analysis and visualisation software. The newest version features the Derwent World Patents Index.
SciFinder 2007, from Chemical Abstracts Service (CAS) will make it easier for scientists to process records more conveniently, and to fine-tune their answer sets for chemistry-related literature, substances, and reactions.
Chemical Abstracts Service has introduced a number of enhancements in the CA and CAplus databases on STN, including additional content and features for more effective patent searching with IPC codes.
Chemical Abstracts Service (CAS) has introduced a number of enhancements in the CA and CAplus databases on STN, including additional content and features for more effective patent searching with IPC codes. IPC-related improvements in CA/CAplus databases include the implementation of all available IPC classifications in patents in the CA/CAplus databases from the Canadian, European, French, German, Japanese, Russian, UK, US and WIPO patent offices.
Elsevier and ExactCure recently announced a collaboration to develop and offer to hospitals – without charge – drug-specific exposure models for 20 already approved medicines that are being tested as potential treatments for Covid-19.
With the world’s focus on the COVID-19 pandemic, LIMS providers are working to develop solutions tailored to assist in the testing and management of virus samples.
Researchers at Harvard Medical School (HMS) have released an open source drug discovery platform, VirtualFlow, that harnesses supercomputing power to screen potentially billions of small organic compound structures in parallel, in the hunt for promising new drug molecules.
When designing a component or system, where do you start? In days gone by, designers would literally go back to the drawing board, using their experience and expertise to develop a new concept.
Effective utilisation of computing tools is critical to both AI and HPC research, with recent projects in both fields highlighting the scientific benefit of carefully managing resources.
Advances in computer vision combined with AI computing are helping pathologists to more accurately identify subtypes of cancer - leading to better treatments for patients, explains Dan Ruderman.
